SALBUTAMOL (ALBUTEROL)

✓ Medically ReviewedRxβ2 AgonistAPPROVED
💡

Quick Summary

Salbutamol (albuterol) is a short-acting beta-2 adrenergic agonist (SABA) that serves as the universal first-line rescue medication for acute bronchospasm. By directly relaxing bronchial smooth muscle, it reverses acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations within minutes. While its respiratory selectivity makes it vastly safer than older bronchodilators, high or frequent doses spill over into systemic circulation, predictably causing tremor, tachycardia, and hypokalaemia. The most critical clinical pitfall is treating worsening asthma with more salbutamol rather than escalating inhaled corticosteroids to control the underlying airway inflammation.

🔬

Drug Identity

GENERIC NAMESalbutamol (Albuterol)
MEDOBO IDMDBD0012
ATC CODER03AC02
DRUG CLASSβ2 Agonist
PHARMACOLOGICAL CLASSShort-Acting β2-Adrenergic Agonist (SABA)
THERAPEUTIC CLASSBronchodilator
THERAPEUTIC CATEGORYRespiratory
CHEMICAL NAMEalpha1-[(tert-butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol sulfate
DRUG SOURCESynthetic
FDA APPROVAL1981
MODALITYSmall Molecule
DRUG TYPEstandard
MARKET STATUS● Approved
CORE USE TAGS
AsthmaCOPDBronchodilatorRescue InhalerWheezing
BRAND NAMES (GLOBAL)
VentolinProAir HFAProventil HFAAsthalinSalamolAerolinAiromirAsmolSalbairReliOn
SYNONYMS
AlbuterolAlbuterol sulfateSalbutamol sulfateAH-3365
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Treatment or prevention of bronchospasm in adults and children aged 4 years and older with reversible obstructive airway disease
  • Prevention of exercise-induced bronchospasm in adults and children aged 4 years and older
🔬 OFF-LABEL USES
  • Hyperkalaemia — temporary adjunctive treatment to drive serum potassium intracellularly
  • Acute anaphylaxis — as an adjunct to adrenaline (epinephrine) for residual bronchospasm
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.